Tigermed is strongly committed to corporate compliance on both a local and global level. You may report concerns to Tigermed confidentially and anonymously by contact information below on matters related to Tigermed’s business activities.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
Learn more about new policies and challenges of drug registration in China from Jianqing Chang, VP of Drug Regulatory Policy, Tigermed.
A deep interpretation of newly updated Measures for the Administration of Drug Registration in China.
After the pilot program in ten provinces and municipal cities for 3 years, the MAH system becomes one of the twelve chapters of the revised Drug Administration Law, which was put into effect since De 1, 2019.
We are committed to supporting our clients in their clinical development in the best possible way.